article thumbnail

Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement

Physician's Weekly

Several authors disclosed ties to relevant organizations, including Eli Lilly, the manufacturer of tirzepatide. Abstract/Full Text (subscription or payment may be required) Copyright © 2025 HealthDay. All rights reserved.

article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

Key proposals included increasing hospital Medicaid reimbursement rates , preventing mid-year changes to prescription drug formularies and establishing a School Health Advisory Committee. 2413 ( Senator Mann ) creates a new assessment on hospitals to increase Medical Assistance reimbursement rates. Read a summary of S.F.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Primary care clinics changes in abortion care after participation in the 2022-23 ExPAND Mifepristone Learning Collaborative [Women's health]

Annals of Family Medicine

Context: The ExPAND Mifepristone (ExPAND) learning collaborative is a year-long program focused on growing the pool of abortion providers by integrating medication abortion into primary care. Objectives: 1) Participating clinics begin to provide mifepristone for early pregnancy loss (EPL) and/or abortion care.

article thumbnail

Advance Care Planning Discussion: Susan Hickman, Sean Morrison, Rebecca Sudore, and Bob Arnold

GeriPal

I worry, as a ex-primary care doctor, how much time I have. And so you could say that’s sort of starting the normalizing that process of advance care planning. And I would say too, as a primary care provider, it really doesn’t take that long to ask people about a surrogate decision maker. Eric: Susan.

Illness 72